Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control ML Grassi, C de Souza Palma, CH Thomé, GP Lanfredi, A Poersch, ... Journal of proteomics 151, 2-11, 2017 | 57 | 2017 |
Protective effect of DCTN (trans-dehydrocrotonin) against induction of micronuclei and apoptosis by different mutagenic agents in vitro A Poersch, FV dos Santos, MAM Maciel, JKP da Câmara, ... Mutation Research/Genetic Toxicology and Environmental Mutagenesis 629 (1 …, 2007 | 40 | 2007 |
A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics A Poersch, ML Grassi, VP de Carvalho, GP Lanfredi, C de Souza Palma, ... Journal of proteomics 145, 226-236, 2016 | 39 | 2016 |
The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers VP De Carvalho, ML Grassi, C de Souza Palma, HHA Carrara, VM Faca, ... Translational Research 206, 71-90, 2019 | 26 | 2019 |
Absence of mutagenicity in somatic and germ cells of mice submitted to subchronic treatment with an extract of Croton cajucara Benth.(Euphorbiaceae) FV Santos, SFP Mesquita, MJSS Faria, A Poersh, MAM Maciel, AC Pinto, ... Genetics and Molecular Biology 29, 159-165, 2006 | 25 | 2006 |
Shiitake (Lentinula edodes (Berkeley) Pegler) extracts as a modulator of micronuclei induced in HEp-2 cells CK Miyaji, A Poersch, LR Ribeiro, AF Eira, IMS Cólus Toxicology in vitro 20 (8), 1555-1559, 2006 | 21 | 2006 |
DNA repair in Etoposide-induced DNA damage in lymphocytes of breast cancer patients and healthy women AC Teixeira, RA Dos Santos, A Poersch, HHA Carrara, JM de Andrade, ... International Journal of Clinical and Experimental Medicine 2 (3), 280, 2009 | 13 | 2009 |
A proteomics outlook towards the elucidation of epithelial–mesenchymal transition molecular events VC Silvestrini, GP Lanfredi, AP Masson, A Poersch, GA Ferreira, ... Molecular omics 15 (5), 316-330, 2019 | 9 | 2019 |
Analysis of ovarian cancer cell secretome during epithelial to mesenchymal transition reveals a protein signature associated with advanced stages of ovarian tumors GP Lanfredi, CH Thome, GA Ferreira, VC Silvestrini, AP Masson, ... Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1869 (6), 140623, 2021 | 6 | 2021 |
Proteomic Analysis of Ovarian Cancer Tumor Fluid is a Rich Source of Potential Biomarkers A Poersch, LO Sousa, LJ Greene, VM Faça, FJ Candido dos Reis Journal of Proteomics and Bioinformatics, 2014 | 4 | 2014 |
Identification of PKM2 as a potential biomarker of high-grade ovarian serous tumor. A Poersch, LO Souza, VM Faca, LJ Greene, FJ Candido dos Reis MOLECULAR CANCER THERAPEUTICS 12 (11), 2013 | 1 | 2013 |
Abstract A191: Profile of ovarian cancer tumor fluid using high-throughput and targeted proteomic analysis A Poersch, ML Grassi, CS Palma, VP Carvalho, GP Lanfredi, ... Molecular Cancer Therapeutics 17 (1_Supplement), A191-A191, 2018 | | 2018 |
Abstract A192: Proteomic analysis of epithelial-to-mesenchymal transition induced by EGF in breast cancer cells CS Palma, ML Grassi, CH Thomé, A Poersch, GP Lanfredi, VM Faça Molecular Cancer Therapeutics 17 (1_Supplement), A192-A192, 2018 | | 2018 |
Profiling Cell Lines Nuclear Sub-proteome A Poersch, AG Maria, CS Palma, ML Grassi, D Albuquerque, CH Thomé, ... Proteomics: Methods and Protocols, 35-46, 2017 | | 2017 |
Avaliação da influência de comorbidades e estilo de vida sobre as expressões das proteínas HE4, MSLN e TIMP1 observadas em fluidos intra-tumorais e plasma sanguíneo de … VP Carvalho, ML Grassi, VM Faça, A Poersch Resumos da Faculdade de Medicina de Ribeirão Preto, 2015 | | 2015 |
Avaliação dos danos no DNA e do grau de recuperação celular em pacientes com câncer de mama submetidas à quimioterapia A Poersch, CS Takahashi | | 2010 |
Molecular Omics VC Silvestrini, GP Lanfredi, AP Masson, A Poersch, GA Ferreira, ... | | |